Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongfu Yiqi Tang is a Traditional Chinese Medicine (TCM) decoction primarily utilized for treating gastrointestinal dysfunction in patients with sepsis. The formula is designed according to the TCM principles of "Tongfu" (unblocking the bowels) and "Yiqi" (supplementing Qi), aiming to restore gastrointestinal motility and modulate the systemic inflammatory response. It typically comprises a combination of herbal ingredients, including *Rheum palmatum* (Da Huang), *Astragalus membranaceus* (Huang Qi), *Magnolia officinalis* (Hou Po), and *Citrus aurantium* (Zhi Shi). In clinical practice, particularly within critical care settings, it is often administered via enema to reduce intra-abdominal pressure and improve intestinal barrier function. Clinical studies, such as those conducted at Tongde Hospital of Zhejiang Province, have explored its efficacy when used in conjunction with electroacupuncture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongfu Yiqi Tang.